Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trials Market Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.The global clinical trials market size was...
-
STAFFORD, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...
-
Dublin, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The "Reflux Esophagitis (Gastroesophageal Reflux Disease) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's...
-
Dublin, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) in Clinical Trials Market" report has been added to ResearchAndMarkets.com's offering.The global market for Artificial...
-
Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Dengue Fever - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The report includes an...
-
Dublin, Nov. 14, 2025 (GLOBE NEWSWIRE) -- The "Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This...
-
Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "CD40 Targeted Therapies Clinical Trials, Therapeutic Approaches, Proprietary Technology Platforms & Market Opportunity Insight 2026" report has...
-
STAFFORD, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...
-
Dublin, July 22, 2025 (GLOBE NEWSWIRE) -- The "Endometriosis - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...
-
Dublin, May 22, 2025 (GLOBE NEWSWIRE) -- The "CD40 Targeted Therapies Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2025" has been added to ResearchAndMarkets.com's...